首页> 美国卫生研究院文献>Molecules >Encapsulation Preserves Antioxidant and Antidiabetic Activities of Cactus Acid Fruit Bioactive Compounds under Simulated Digestion Conditions
【2h】

Encapsulation Preserves Antioxidant and Antidiabetic Activities of Cactus Acid Fruit Bioactive Compounds under Simulated Digestion Conditions

机译:在模拟消化条件下包封保留仙人掌酸果生物活性化合物的抗氧化剂和抗糖尿病活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cactus acid fruit (Xoconostle) has been studied due its content of bioactive compounds. Traditional Mexican medicine attributes hypoglycemic, hypocholesterolemic, anti-inflammatory, antiulcerogenic and immunostimulant properties among others. The bioactive compounds contained in xoconostle have shown their ability to inhibit digestive enzymes such as α-amylase and α-glucosidase. Unfortunately, polyphenols and antioxidants in general are molecules susceptible to degradation due to storage conditions, (temperature, oxygen and light) or the gastrointestinal tract, which limits its activity and compromises its potential beneficial effect on health. The objectives of this work were to evaluate the stability, antioxidant and antidiabetic activity of encapsulated extract of xoconostle within double emulsions (water-in-oil-in-water) during storage conditions and simulated digestion. Total phenols, flavonoids, betalains, antioxidant activity, α-amylase and α-glucosidase inhibition were measured before and after the preparation of double emulsions and during the simulation of digestion. The ED40% (treatment with 40% of xoconostle extract) treatment showed the highest percentage of inhibition of α-glucosidase in all phases of digestion. The inhibitory activity of α-amylase and α-glucosidase related to antidiabetic activity was higher in microencapsulated extracts than the non-encapsulated extracts. These results confirm the viability of encapsulation systems based on double emulsions to encapsulate and protect natural antidiabetic compounds.
机译:已经研究了仙人掌酸果(Xoconostle)由于其生物活性化合物的含量。传统的墨西哥药属于降血糖,脱粒细胞,抗炎,抑制性和免疫刺激性特性。 Xoconostle中含有的生物活性化合物表明它们能够抑制消化酶如α-淀粉酶和α-葡糖苷酶。遗憾的是,多酚和抗氧化剂通常是由于储存条件(温度,氧气和光)或胃肠道而易受降解的分子,这限制了其活性并损害其对健康的潜在有益影响。本作作品的目的是评估储存条件下双乳液(水包内水)内XOCONOUTLE的包封提取物的稳定性,抗氧化剂和抗糖尿病活性和模拟消化。在制备双乳液之前和在消化的模拟期间,测量总酚,黄酮类化合物,β,抗氧化活性,α-淀粉酶和α-葡糖苷酶抑制。 ED40%(用40%的Xoconostle提取物处理)治疗显示出在消化的所有阶段中α-葡糖苷酶的抑制率最高。微囊化提取物的α-淀粉酶和α-葡糖苷酶的抑制活性比未包封的提取物高。这些结果证实了基于双乳液的封装系统的可行性,用于包封和保护天然抗糖尿病化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号